Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)

China flag China · Delayed Price · Currency is CNY
6.68
+0.01 (0.15%)
At close: Feb 13, 2026
Market Cap3.69B +34.8%
Revenue (ttm)1.79B -9.2%
Net Income46.95M -47.5%
EPS0.08 -47.1%
Shares Out552.92M
PE Ratio78.76
Forward PEn/a
Dividend0.03 (0.42%)
Ex-Dividend DateJan 9, 2026
Volume10,781,840
Average Volume21,453,981
Open6.71
Previous Close6.67
Day's Range6.66 - 6.76
52-Week Range4.51 - 9.44
Beta0.83
RSI46.34
Earnings DateApr 15, 2026

About SHA:600222

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of pharmaceutical preparations and Chinese herbal medicines in China. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, pediatric Qingrezhike oral liquid, Huoxiangzhengqi mixture, Danshen and Wuzi Yanzong oral liquid, Shengmaiyin, pediatric compound chicken gizzard chewable tablets, Huperzine A tablets, compound Yimu oral liquid. The company serves hospitals, primary medical institutions, and retail terminals. Henan T... [Read more]

Sector Healthcare
Founded 1993
Employees 2,214
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600222
Full Company Profile

Financial Performance

In 2024, SHA:600222's revenue was 1.94 billion, a decrease of -6.21% compared to the previous year's 2.07 billion. Earnings were 50.53 million, an increase of 16.00%.

Financial Statements